AIM ImmunoTech Inc. (AIM) AMEX
0.56
+0.0163(+2.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.56
+0.0163(+2.99%)
Currency In USD
| Market Cap | 1.83M |
| Enterprise Value | 5.79M |
| P/E Ratio | -0.12 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 21.74 |
| Price/Book Ratio | -0.18 |
| Enterprise/Revenue | 66.79 |
| Enterprise/EBITDA | -0.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -158.61 |
| Operating Margin | -126.6 |
| Return On Assets | -2.41 |
| Return On Equity | 2.13 |
| Revenue | 88,000 |
| Revenue/Share | 0.03 |
| Gross Profit | -250,000 |
| EBITDA | -10.32M |
| Net Income | -13.96M |
| Diluted EPS | -8.62 |
| Total Cash | 993,000 |
| Total Cash/Share | 0.32 |
| Total Debt | 4.9M |
| Total Debt/Equity | -0.5 |
| Current Ratio | 0.53 |
| Book Value Per Share | -3.18 |
| 52-Week Change | -85.05 |
| 52-Week High | 19.74 |
| 52-Week Low | 0.51 |
| Moving Average 50 Days | 0.81 |
| Moving Average 200 Days | 2.3 |
| Average Volume | 4.67M |
| Shares Outstanding | 3.4M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1031:1000 |
| Last Split Date | February 10, 2026 |